We are drafting the disclosure schedules for our definitive purchase agreement, and our attorney wants us to list every minor operational non-compliance, which we worry will give the buyer ammunition to renegotiate the price. How do we use our EOS® historical data and the Business Integrity Review to streamline this disclosure process without triggering a price re-trade?

Question

Tyler Smith · Accepted Answer

Disclosure schedules are designed to transfer risk from the seller to the buyer. If you fail to disclose a material issue and it causes a loss after close, the buyer can sue you for a breach of representations and warranties. However, dumping a disorganized list of minor operational issues onto the buyer at the last minute invites them to re-trade the valuation.

To prevent this, use the results of your Step by Step Exit Business Integrity Review to categorize your risks early. The Business Integrity Review helps you identify which operational vulnerabilities are actually material to a buyer and which are minor day-to-day issues.

For the material items, write clear, objective descriptions supported by your historical data. Present the issue alongside the operational solution you already implemented. For example, if you had a past compliance issue, show the corrected process on your Accountability Chart and prove through your weekly scorecard metrics that the issue has been resolved for multiple quarters.

For minor operational details, group them logically into single disclosures rather than listing dozens of individual items. This keeps the schedules clean and professional. By presenting your disclosures as a controlled, well-managed component of your operational history, you demonstrate to the buyer that you run a disciplined company, leaving them no room to claim that undisclosed risks justify a price reduction.